NBRC Pharmacology Practice Exam

Inhaled corticosteroids are particularly effective in the management of asthma because they help to reduce airway inflammation and hyperresponsiveness, which are key components of the pathophysiology of asthma. These medications work by directly targeting the underlying inflammatory processes in the airways, leading to improved lung function and reduced frequency of asthma exacerbations.

In asthma, the airways can become inflamed and narrowed, making it difficult to breathe. By using inhaled corticosteroids, patients can achieve better control of their symptoms, allowing for a more stable and manageable condition. This treatment approach is supported by guidelines that recommend inhaled corticosteroids as a first-line therapy for persistent asthma.

Other conditions like acute bronchitis, pneumonia, and pulmonary fibrosis do not typically respond to inhaled corticosteroids in the same manner. Acute bronchitis is usually caused by viral infections, and its treatment focuses more on symptomatic relief rather than anti-inflammatory therapy. Pneumonia, an infection of the lungs, usually requires antibiotics or antiviral medications. Pulmonary fibrosis involves scarring of lung tissue and often requires different therapeutic strategies, such as antifibrotic agents or oxygen therapy, rather than corticosteroid treatment. Therefore, the use of inhaled corticosteroids is specifically indicated and most beneficial in the